Ignite Creation Date:
2025-12-25 @ 3:31 AM
Ignite Modification Date:
2026-01-27 @ 2:56 PM
Study NCT ID:
NCT06711705
Status:
RECRUITING
Last Update Posted:
2025-02-11
First Post:
2024-11-12
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Elranatamab in Relapsed/Refractory Multiple Myeloma
Sponsor:
Organization: